Xylem, Inc. (XYL) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1163007,
    "name": "Xylem, Inc.",
    "stock_name": "Xylem, Inc.",
    "full_name": "Xylem, Inc.",
    "name_url": "stocks-analysis/xylem-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "140.87",
    "chg": -0.02,
    "chgp": "-0.01%",
    "dir": -1,
    "prev_price": "140.89",
    "mcapval": "36,213.11",
    "mcap": "Mid Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Industrial Manufacturing",
    "ind_code": 1210,
    "indexname": "S&P 500",
    "isin": "US98419M1009",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "780.65 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/xylem-inc-1163007-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3673440",
        "imagepath": "",
        "date": "2025-11-05 11:11:43",
        "description": "As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a significantly higher P/E of 52.55, while Dover Corp. is at 43.35, suggesting that Xylem's valuation is not as extreme as some competitors but still elevated.\n\nDespite a strong year-to-date return of 29.02% compared to the S&P 500's 16.30%, Xylem's longer-term performance has lagged behind, with a 5-year return of 63.40% versus the S&P 500's 109.18%. This discrepancy reinforces the notion that while Xylem has performed well recently, its current valuation may not be justified given its relative performance and the valuation metrics compared to its pee..."
      },
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3666204",
        "imagepath": "",
        "date": "2025-11-03 11:17:05",
        "description": "As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. Despite this change, the company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03, all of which suggest that the stock is trading at a premium compared to its peers.\n\nIn comparison, Ingersoll Rand, Inc. has a higher P/E ratio of 52.55, while Dover Corp. is more fairly valued with a P/E of 43.35. This places Xylem in a relatively expensive position within its industry. Additionally, while Xylem has shown strong returns, with a year-to-date return of 30.02% compared to the S&P 500's 16.30%, its three-year return of 47.27% lags behind the S&P 500's 76.66%. This performance suggests that, despite recent gains, the stock's valuation may not be justified in t..."
      },
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3664332",
        "imagepath": "",
        "date": "2025-11-02 11:10:07",
        "description": "As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. However, the company remains overvalued based on its current metrics. The P/E ratio stands at 35, significantly higher than the industry average, while the EV to EBITDA ratio is 20.21, and the PEG ratio is 1.10, suggesting that the stock is priced for growth that may not materialize.\n\nIn comparison to its peers, Xylem, Inc. has a P/E ratio of 37.49, which is higher than Dover Corp.'s fair valuation at 43.35 and significantly lower than Ingersoll Rand, Inc.'s very expensive rating at 52.55. The company's recent performance shows a 30.02% return year-to-date, outperforming the S&P 500's 16.30% in the same period, but it lags behind the S&P 500 over longer horizons, particularly in the 3-year and 5-year returns. Overall, Xylem, Inc. appears to be overvalued ..."
      },
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3637878",
        "imagepath": "",
        "date": "2025-10-21 12:10:46",
        "description": "As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating that the company is overvalued. Key ratios supporting this assessment include a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03. In comparison, peers such as Ingersoll Rand, Inc. have a higher P/E of 52.55, while Dover Corp. presents a more attractive P/E of 43.35, highlighting Xylem's relatively high valuation within its industry.\n\nDespite a strong year-to-date return of 25.76%, which outperformed the S&P 500's 13.30%, the long-term performance shows a decline, with a 3-year return of 61.14% compared to the S&P 500's 81.19%. This suggests that while Xylem has performed well recently, its current valuation may not be justified given the overall market performance and peer comparisons...."
      },
      {
        "title": "Xylem, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xylem-inc-sees-valuation-grade-shift-from-fair-to-expensive-amid-stock-price-increase-3641022",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XylemInc_valuationdot_3641022.png",
        "date": "2025-10-20 17:10:23",
        "description": "Xylem, Inc., a midcap industrial manufacturer, has adjusted its valuation, currently priced at $145.91. Over the past year, it has returned 7.95%, lagging behind the S&P 500. Key metrics include a P/E ratio of 35 and a dividend yield of 111.76%, reflecting its competitive position in the industry."
      },
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3634744",
        "imagepath": "",
        "date": "2025-10-20 12:27:59",
        "description": "As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on several key metrics, including a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03. In comparison to peers, Xylem's P/E ratio is lower than Ingersoll Rand, Inc. at 52.55, but higher than Dover Corp. at 43.35, suggesting that while it is relatively less expensive than some, it still commands a premium in the market.\n\nThe company's recent stock performance shows a YTD return of 25.76%, which outpaces the S&P 500's 13.30% return, but over longer periods, such as 3Y and 5Y, Xylem significantly lags behind the benchmark, with returns of 61.14% and 59.43% respectively compared to the S&P 500's 81.19% and 91.29%. This divergence in performance reinforces the notion that Xylem may be overvalued in the current market ..."
      },
      {
        "title": "Is Xylem, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xylem-inc-overvalued-or-undervalued-3632283",
        "imagepath": "",
        "date": "2025-10-19 12:05:26",
        "description": "As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a higher P/E of 52.55, while Dover Corp. shows a more attractive P/E of 43.35, suggesting that Xylem's valuation is not justified relative to its industry counterparts.\n\nDespite a year-to-date return of 25.76%, which outperformed the S&P 500's 13.30%, the longer-term performance indicates that Xylem has lagged behind the index over three and five years, with returns of 61.14% and 59.43% respectively, compared to the S&P 500's 81.19% and 91.29%. This performance, combined with the current valuation metrics, reinforces the conclusion that Xylem, Inc. is overvalued...."
      },
      {
        "title": "Xylem, Inc. Hits New 52-Week High at USD 151.16",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xylem-inc-hits-new-52-week-high-at-usd-15116-3601667",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XylemInc_priceRelatedfactors_3601667.png",
        "date": "2025-10-07 21:56:09",
        "description": "Xylem, Inc. has achieved a new 52-week high, reflecting its strong operational performance in the industrial manufacturing sector. The company has a market capitalization of USD 36.2 billion, a P/E ratio of 35.00, and a low debt-to-equity ratio of 0.09, indicating solid financial health."
      },
      {
        "title": "Xylem, Inc. Hits New 52-Week High at $150.98",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/xylem-inc-hits-new-52-week-high-at-15098-3595661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/XylemInc_priceRelatedfactors_3595661.png",
        "date": "2025-10-06 17:38:19",
        "description": "Xylem, Inc. has achieved a new 52-week high of USD 150.98 as of October 3, 2025, reflecting its strong performance in the industrial manufacturing sector. The stock has risen 7.61% over the past year, showcasing the company's resilience and adaptability in a competitive market."
      }
    ],
    "total": 21,
    "sid": "1163007",
    "stock_news_url": "https://www.marketsmojo.com/news/xylem-inc-1163007"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Xylem, Inc. overvalued or undervalued?

2025-11-05 11:11:43

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a significantly higher P/E of 52.55, while Dover Corp. is at 43.35, suggesting that Xylem's valuation is not as extreme as some competitors but still elevated. Despite a strong year-to-date return of 29.02% compared to the S&P 500's 16.30%, Xylem's longer-term performance has lagged behind, with a 5-year return of 63.40% versus the S&P 500's 109.18%. This discrepancy reinforces the notion that while Xylem has performed well recently, its current valuation may not be justified given its relative performance and the valuation metrics compared to its pee...

Is Xylem, Inc. overvalued or undervalued?

2025-11-03 11:17:05

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. Despite this change, the company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03, all of which suggest that the stock is trading at a premium compared to its peers. In comparison, Ingersoll Rand, Inc. has a higher P/E ratio of 52.55, while Dover Corp. is more fairly valued with a P/E of 43.35. This places Xylem in a relatively expensive position within its industry. Additionally, while Xylem has shown strong returns, with a year-to-date return of 30.02% compared to the S&P 500's 16.30%, its three-year return of 47.27% lags behind the S&P 500's 76.66%. This performance suggests that, despite recent gains, the stock's valuation may not be justified in t...

Is Xylem, Inc. overvalued or undervalued?

2025-11-02 11:10:07

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. However, the company remains overvalued based on its current metrics. The P/E ratio stands at 35, significantly higher than the industry average, while the EV to EBITDA ratio is 20.21, and the PEG ratio is 1.10, suggesting that the stock is priced for growth that may not materialize. In comparison to its peers, Xylem, Inc. has a P/E ratio of 37.49, which is higher than Dover Corp.'s fair valuation at 43.35 and significantly lower than Ingersoll Rand, Inc.'s very expensive rating at 52.55. The company's recent performance shows a 30.02% return year-to-date, outperforming the S&P 500's 16.30% in the same period, but it lags behind the S&P 500 over longer horizons, particularly in the 3-year and 5-year returns. Overall, Xylem, Inc. appears to be overvalued ...

Is Xylem, Inc. overvalued or undervalued?

2025-10-21 12:10:46

As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating that the company is overvalued. Key ratios supporting this assessment include a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03. In comparison, peers such as Ingersoll Rand, Inc. have a higher P/E of 52.55, while Dover Corp. presents a more attractive P/E of 43.35, highlighting Xylem's relatively high valuation within its industry. Despite a strong year-to-date return of 25.76%, which outperformed the S&P 500's 13.30%, the long-term performance shows a decline, with a 3-year return of 61.14% compared to the S&P 500's 81.19%. This suggests that while Xylem has performed well recently, its current valuation may not be justified given the overall market performance and peer comparisons....

Xylem, Inc. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape

2025-10-20 17:10:23

Xylem, Inc., a midcap industrial manufacturer, has adjusted its valuation, currently priced at $145.91. Over the past year, it has returned 7.95%, lagging behind the S&P 500. Key metrics include a P/E ratio of 35 and a dividend yield of 111.76%, reflecting its competitive position in the industry.

Is Xylem, Inc. overvalued or undervalued?

2025-10-20 12:27:59

As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on several key metrics, including a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03. In comparison to peers, Xylem's P/E ratio is lower than Ingersoll Rand, Inc. at 52.55, but higher than Dover Corp. at 43.35, suggesting that while it is relatively less expensive than some, it still commands a premium in the market. The company's recent stock performance shows a YTD return of 25.76%, which outpaces the S&P 500's 13.30% return, but over longer periods, such as 3Y and 5Y, Xylem significantly lags behind the benchmark, with returns of 61.14% and 59.43% respectively compared to the S&P 500's 81.19% and 91.29%. This divergence in performance reinforces the notion that Xylem may be overvalued in the current market ...

Is Xylem, Inc. overvalued or undervalued?

2025-10-19 12:05:26

As of 17 October 2025, the valuation grade for Xylem, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a higher P/E of 52.55, while Dover Corp. shows a more attractive P/E of 43.35, suggesting that Xylem's valuation is not justified relative to its industry counterparts. Despite a year-to-date return of 25.76%, which outperformed the S&P 500's 13.30%, the longer-term performance indicates that Xylem has lagged behind the index over three and five years, with returns of 61.14% and 59.43% respectively, compared to the S&P 500's 81.19% and 91.29%. This performance, combined with the current valuation metrics, reinforces the conclusion that Xylem, Inc. is overvalued....

Xylem, Inc. Hits New 52-Week High at USD 151.16

2025-10-07 21:56:09

Xylem, Inc. has achieved a new 52-week high, reflecting its strong operational performance in the industrial manufacturing sector. The company has a market capitalization of USD 36.2 billion, a P/E ratio of 35.00, and a low debt-to-equity ratio of 0.09, indicating solid financial health.

Xylem, Inc. Hits New 52-Week High at $150.98

2025-10-06 17:38:19

Xylem, Inc. has achieved a new 52-week high of USD 150.98 as of October 3, 2025, reflecting its strong performance in the industrial manufacturing sector. The stock has risen 7.61% over the past year, showcasing the company's resilience and adaptability in a competitive market.

View All News